Get All Access for FREEMarket News & Research,
Live Transcripts & Audio,
and a whole lot more…
The BoD of $AOS approved a 29% increase in its quarterly cash dividend to $0.18 per share. This is consistent with the 5-year compound annual growth rate of its dividend which is over 25%. The dividend is payable on Feb. 15, 2018, to shareholders of record Jan. 31, 2018.
$ACET's finished dosage form generics subsidiary Rising Pharmaceuticals launched the first generic for Efavirenz Capsules. This is an FDA-approved generic version of the reference listed drug, Sustiva from $BMY, which in combination with other drugs is indicated for the treatment of HIV-1 infection in adults and pediatric patients.
European Group B.V., a subsidiary of $OI, launches private offering of $310MM of Senior Notes due 2023. The company expects to use the net proceeds from the private offering and the cash from the balance sheet, to repay the Euro-denominated term loan A facility under the credit agreement.
$CLX announced the official opening of a new manufacturing facility for the company's Home Care products. Named Atlanta West, the 258,000-sq.ft. facility is adjacent to the company's existing manufacturing facility, called Atlanta Main. The opening of Atlanta West has created about 100 jobs in Clayton County.
$RBC said Charles Hinrichs, VP and CFO, will retire on March 31, 2018. Hinrichs has served as Regal's CFO since September 2010. The BoD appointed Robert Rehard as the new VP and CFO, effective April 1, 2018. Rehard joined Regal in January 2015 as VP, Corporate Controller and Principal Accounting Officer.
$IPHS has acquired NutraGenesis, a Vermont-based marketer of branded nutraceutical ingredients, for a total purchase price of $28MM in cash. $IPHS funded the acquisition with borrowings under its existing credit facility. The acquisition is expected to be accretive to the company’s EPS in the first year following the close of the transaction.
$WST, a pharmaceutical services firm, said a recent study showed its injection guide ID Adaptor could be used for administering intradermal injections in a safe and effective manner. The clinical trial evaluated the feasibility of conducting a door-to-door vaccination campaign to administer Fractional Inactivated Poliovirus Vaccine to children.
$PKG has completed its acquisition of the assets of Sacramento Container Corporation and 100% of the membership interests of Northern Sheets, LLC and Central California Sheets, LLC in a cash-free, debt-free transaction. Funding for the $265MM purchase price came from available cash on hand.